2-O-甲基-D-半乳糖 | 2140-41-2

• 分子结构分类: 有机化合物 - 有机氧化合物
• 中文名称: 2-O-甲基-D-半乳糖
• 英文名称: 2-O-Methyl-D-galactose
• 英文别名: 2-O-Methyl-D-mannose；6-(Hydroxymethyl)-3-methoxyoxane-2,4,5-triol
• CAS: 2140-41-2；14199-60-1；14251-16-2；18968-07-5；18968-08-6；20972-03-6；24436-13-3；27552-09-6；31505-23-4；32445-62-8；32445-63-9；32445-65-1；32445-66-2
• 化学式: C₇H₁₄O₆
• 分子量: 194.185
• InChiKey: UMPNFVHHMOSNAC-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  -2.1
• 重原子数：
  13
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  99.4
• 氢给体数：
  4
• 氢受体数：
  6

安全信息

• 海关编码：
  2932999099

文献信息

• [EN] INHIBITORS OF ALDOSE REDUCTASE<br/>[FR] INHIBITEURS DE L'ALDOSE RÉDUCTASE
  申请人：APPLIED THERAPEUTICS INC

  公开号：WO2020205846A1

  公开（公告）日：2020-10-08

  The present disclosure relates to novel compounds and pharmaceutical compositions thereof, and methods for promoting healthy aging of skin, the treatment of skin disorders, the treatment of cardiovascular disorders, the treatment of renal disorders, the treatment of angiogenesis disorders, such as cancer, treatment of tissue damage, such as non-cardiac tissue damage, the treatment of evolving myocardial infarction, the treatment of ischemic injury, and the treatment of various other disorders, such as complications arising from diabetes with the compounds and compositions of the invention. Other disorders can include, but are not limited to, atherosclerosis, cardiomyopathy, coronary artery disease, diabetic nephropathy, diabetic neuropathy, diabetic retinopathy, diabetic cardiomyopathy, infections of the skin, peripheral vascular disease, stroke, galactosemia, asthma, PMM2-CDG and the like.

  本公开涉及新颖化合物及其药物组合物，以及促进皮肤健康老化、治疗皮肤疾病、心血管疾病、肾脏疾病、血管生成障碍（如癌症）、组织损伤治疗（如非心脏组织损伤）、心肌梗死演变治疗、缺血性损伤治疗以及利用本发明的化合物和组合物治疗糖尿病引起的并发症等方法。其他疾病可能包括但不限于动脉粥样硬化、心肌病、冠状动脉疾病、糖尿病肾病、糖尿病神经病变、糖尿病视网膜病变、糖尿病心肌病、皮肤感染、外周血管疾病、中风、半乳糖血症、哮喘、PMM2-CDG等。
• Process for the production of fine chemicals
  申请人：Puzio Piotr

  公开号：US20070118916A1

  公开（公告）日：2007-05-24

  The present invention relates to a process for the production of the fine chemical in a microorganism, a plant cell, a plant, a plant tissue or in one or more parts thereof, preferably in plastids. The invention furthermore relates to nucleic acid molecules, polypeptides, nucleic acid constructs, vectors, antibodies, host cells, plant tissue, propagation material, harvested material, plants, microorganisms as well as agricultural compositions and to their use.

  本发明涉及一种在微生物、植物细胞、植物、植物组织或其一部分中生产精细化学品的过程，优选在质体中进行。此外，本发明还涉及核酸分子、多肽、核酸构建物、载体、抗体、宿主细胞、植物组织、繁殖材料、收获材料、植物、微生物以及农业组合物以及它们的用途。
• Process for the production of lutein
  申请人：Metanomics GmbH

  公开号：EP2096177A2

  公开（公告）日：2009-09-02

  The present invention relates further to a process for the control of the production of fine chemical in a microorganism, a plant cell, a plant, a plant tissue or in one or more parts thereof. The invention furthermore relates to nucleic acid molecules, polypeptides, nucleic acid constructs, vectors, antisense molecules, antibodies, host cells, plant tissue, propagation material, harvested material, plants, microorganisms as well as agricultural compositions and to their use.

  本发明还涉及一种控制微生物、植物细胞、植物、植物组织或其一个或多个部分生产精细化学品的工艺。本发明还涉及核酸分子、多肽、核酸构建体、载体、反义分子、抗体、宿主细胞、植物组织、繁殖材料、收获材料、植物、微生物以及农业组合物及其用途。
• Process for the control of production of fine chemicals
  申请人：Metanomics GmbH

  公开号：EP2368905A2

  公开（公告）日：2011-09-28

  The present invention relates to a process for the control of the production of fine chemical in a microorganism, a plant cell, a plant, a plant tissue or in one or more parts thereof. The invention furthermore relates to nucleic acid molecules, polypeptides, nucleic acid constructs, vectors, antisense molecules, antibodies, host cells, plant tissue, propagation material, harvested material, plants, microorganisms as well as agricultural compositions and to their use.

  本发明涉及一种控制微生物、植物细胞、植物、植物组织或其一个或多个部分生产精细化学品的工艺。本发明还涉及核酸分子、多肽、核酸构建体、载体、反义分子、抗体、宿主细胞、植物组织、繁殖材料、收获材料、植物、微生物以及农业组合物及其用途。
• PROCESS FOR THE PRODUCTION OF FINE CHEMICALS
  申请人：Metanomics GmbH

  公开号：EP1765857A2

  公开（公告）日：2007-03-28